1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Oh, D.
Shin, S.Y.
Lee, S.
Kim, Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
11855
11864
10.1021/bi000453g
11009597
Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.
2000
10.2210/pdb1f0g/pdb
pdb_00001f0g
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2337.998
CECROPIN A-MAGAININ 2 HYBRID PEPTIDE
W28L
1
syn
polymer
no
yes
KLKLFKKIGIGKFLHSAKKF(NH2)
KLKLFKKIGIGKFLHSAKKFX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-06-14
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_spectrometer.model
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
RCSB
Y
RCSB
2000-05-16
REL
THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE FOR THIS PEPTIDE IS A HYBRID OF SEQUENCES WHICH OCCUR NATURALLY IN HYALOPHORA CECROPIA (CECROPIA MOTH) AND XENOPUS LAEVIS (AFRICAN CLAWED FROG)
sample
structures with the lowest energy
50
20
2D NOESY
3.64
298
K
Distance Geometry-Dynamical Simulated Annealing Hybrid Method
DODECYLPHOSPHOCHOLINE-d38 MICELLES
90% H2O/10% D2O
Brunger, A.T.
refinement
X-PLOR
3.851
400
Bruker
AVANCE
LYS
1
n
1
LYS
1
A
LEU
2
n
2
LEU
2
A
LYS
3
n
3
LYS
3
A
LEU
4
n
4
LEU
4
A
PHE
5
n
5
PHE
5
A
LYS
6
n
6
LYS
6
A
LYS
7
n
7
LYS
7
A
ILE
8
n
8
ILE
8
A
GLY
9
n
9
GLY
9
A
ILE
10
n
10
ILE
10
A
GLY
11
n
11
GLY
11
A
LYS
12
n
12
LYS
12
A
PHE
13
n
13
PHE
13
A
LEU
14
n
14
LEU
14
A
HIS
15
n
15
HIS
15
A
SER
16
n
16
SER
16
A
ALA
17
n
17
ALA
17
A
LYS
18
n
18
LYS
18
A
LYS
19
n
19
LYS
19
A
PHE
20
n
20
PHE
20
A
NH2
21
n
21
NH2
21
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
9
A
A
O
H
GLY
LYS
9
12
1.57
14
A
A
O
H
ILE
GLY
8
11
1.55
1
A
LEU
2
179.59
86.37
2
A
LEU
2
62.83
125.53
2
A
ILE
10
-89.93
42.06
3
A
LEU
2
49.22
81.84
3
A
ILE
8
-64.10
-70.59
4
A
LEU
2
58.39
119.61
4
A
LYS
3
-160.13
46.36
6
A
LYS
3
-90.48
35.06
6
A
LYS
7
-85.87
35.69
7
A
LEU
2
42.90
89.47
9
A
LEU
2
56.22
116.40
11
A
LEU
2
56.90
117.13
11
A
ILE
10
-140.18
28.53
12
A
LEU
2
60.55
124.03
13
A
LEU
2
59.67
130.22
13
A
LYS
3
-109.60
54.88
14
A
LEU
4
-91.54
36.92
15
A
LEU
2
55.61
-172.90
15
A
LYS
19
-143.24
11.28
16
A
LYS
3
-153.67
70.19
17
A
LEU
2
-57.08
99.15
18
A
LEU
2
60.67
121.30
19
A
LEU
2
57.16
145.50
20
A
ILE
10
-94.16
38.89
Cecropin A(1-8)-magainin 2(1-12) L2 in dodecylphosphocholine micelles
1
N
N
A
LEU
4
A
LEU
4
HELX_P
A
GLY
9
A
GLY
9
5
1
6
covale
1.305
both
A
PHE
20
A
C
PHE
20
1_555
A
NH2
21
A
N
NH2
21
1_555
ANTIMICROBIAL PROTEIN
Helix-Turn-Helix, ANTIMICROBIAL PROTEIN
CECA_HYACE
UNP
1
P01507
MAGA_XENLA
UNP
1
P11006
27
34
1F0G
1
8
P01507
A
1
1
8
83
94
1F0G
9
20
P11006
A
2
9
20
1
TRP
engineered mutation
LEU
2
1F0G
A
P01507
UNP
28
2
BINDING SITE FOR RESIDUE NH2 A 21
A
NH2
21
Software
2
A
ALA
17
A
ALA
17
2
1_555
A
PHE
20
A
PHE
20
2
1_555
1
P 1